In clinical studies, "RAR" is sometimes used as an abbreviation for the Red cell distribution width to Albumin Ratio . This ratio is an emerging biomarker used to predict medical outcomes, such as lymph node metastasis in gastric cancer patients.
Research indicates that certain RAR subtypes, specifically RAR 10273 rar
Retinoids that bind to RARs are widely used in topical formulations to treat skin conditions and are studied for their chemopreventive properties against oral malignancies. Potential Technical Interpretation In clinical studies, "RAR" is sometimes used as